Bristol Myers Squibb

Bristol Myers Squibb (BMS) is a prominent global biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for serious diseases. Established in 1989 through the merger of Bristol-Myers Company and Squibb Corporation, BMS is headquartered in Princeton, New Jersey. The company is publicly traded on the New York Stock Exchange under the ticker symbol BMY and is part of the S&P 100 and S&P 500 indices. BMS specializes in the full lifecycle of pharmaceutical product development, including drug discovery, clinical development, manufacturing, and commercialization. The company has a diverse portfolio that addresses major therapeutic areas such as oncology, hematology, immunology, cardiovascular, and neuroscience. Key products include Eliquis, Opdivo, and Revlimid, among others. With a workforce of over 34,000 employees, BMS operates globally, serving patients in various countries and focusing on advancing therapies like CAR-T cell therapies and radiopharmaceuticals.